For instance, MMPs can cleave interleukin-2 receptor (IL-2R), an upregulator of T lymphocyte proliferation [149], and can activate TGF, an important inhibitor of the T-lymphocyte response against tumours [150], thereby suppressing the anti-tumour activity of T lymphocytes. Here, IL2RA is linked to neoplasm.